Brain-scan guided rTMS for treatment-resistant depression
Part of Mental health clinical trials.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 65 years old
- You have major depression confirmed by a study clinician
- Your depression is at least moderately severe (Hamilton score 18 or higher)
- In this current episode, at least one antidepressant at a proper dose and time did not help you
- You can safely have MRI scans
- You can give consent and allow the study team to talk with your own outpatient clinician
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early brain-wave patterns that could help personalize treatment for people with depression that hasn't responded to medication. Researchers will use brain imaging and a non-invasive brain stimulation technique to see if these patterns can predict who benefits most from treatment.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This trial tests whether a non-surgical brain stimulation technique (rTMS) can reduce depression symptoms in adults with major depression. You would likely have several study visits that include brain scans (MRI) and treatment sessions to see if symptoms improve.
This study looks at brain and heart-related measurements to predict who is most likely to improve with rTMS (repetitive transcranial magnetic stimulation) for depression. It may help future patients by identifying markers of treatment response.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
This trial studies signs in the brain (biomarkers) during an accelerated form of nerve stimulation to treat depression that hasn’t improved with usual antidepressants. It may help researchers learn who benefits and how to better personalize treatment.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.